Hong Liang

发表

Developing a Novel Indium(III) Agent Based on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer by Multitargeting the Tumor Microenvironment Components.

Ming Jiang, Yong Chu, Tongfu Yang, 2021, Journal of medicinal chemistry.

Human serum albumin-based dual-agent delivery systems for combination therapy: acting against cancer cells and inhibiting neovascularization in the tumor microenvironment.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2020, Molecular pharmaceutics.

Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.

C. Cheeseman, Hong Liang, Piyush Kumar, 2012, Journal of medicinal chemistry.

Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA Subdomain.

Zhenlei Zhang, Hong Liang, Feng Yang, 2016, Molecular pharmaceutics.

Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2019, European journal of medicinal chemistry.

Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives.

Qi-Pin Qin, Hong Liang, Ming-Xiong Tan, 2019, European journal of medicinal chemistry.

Per os administered refined olive oil and marine PUFA-rich oils reach the cornea: possible role on oxidative stress through caveolin-1 modulation

Hong Liang, M. Dutot, J. Warnet, 2009, Nutrition & metabolism.

Target Profiling of an Iridium(III)-Based Immunogenic Cell Death Inducer Unveils the Engagement of Unfolded Protein Response Regulator BiP.

A. Chan, Hong Liang, Yuan Wang, 2022, Journal of the American Chemical Society.

Corneal Protection With High-Molecular-Weight Hyaluronan Against In Vitro and In Vivo Sodium Lauryl Sulfate-Induced Toxic Effects

Hong Liang, M. Dutot, J. Warnet, 2009, Cornea.

Effects of toxic cellular stresses and divalent cations on the human P2X7 cell death receptor

Hong Liang, C. Baudouin, M. Dutot, 2008, Molecular Vision.

Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2020, Journal of medicinal chemistry.

Designing anticancer multitarget metal thiosemicarbazone prodrug based on the nature of binding sites of human serum albumin carrier.

Hong Liang, Feng Yang, 2018, Future medicinal chemistry.

HSA IIA subdomain-based developing anticancer metal prodrug: a new and improved approach.

Hong Liang, Feng Yang, 2016, Future medicinal chemistry.

Antitumor lignanamides from the aerial parts of Corydalis saxicola.

Ri-zhen Huang, Hong Liang, Lumei Dai, 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Imaging and therapeutic applications of Zn(ii)-cryptolepine-curcumin molecular probes in cell apoptosis detection and photodynamic therapy.

Qi-Pin Qin, Zuzhuang Wei, Huahong Zou, 2020, Chemical communications.

Folate-functionalized human serum albumin carrier for anticancer copper(II) complexes derived from natural plumbagin.

Hong Liang, Feng Yang, Y. Gou, 2015, Journal of inorganic biochemistry.

High anticancer activity and apoptosis- and autophagy-inducing properties of novel lanthanide(III) complexes bearing 8-hydroxyquinoline-N-oxide and 1,10-phenanthroline.

Qi-Pin Qin, Zuzhuang Wei, Hong Liang, 2021, Dalton transactions.

Mitochondria-localizing curcumin-cryptolepine Zn(II) complexes and their antitumor activity.

Qi-Pin Qin, Zuzhuang Wei, Hong Liang, 2020, Bioorganic & medicinal chemistry.

Antioxidant Activities of Plumbagin and Its Cu (II) Complex

Zhenfeng Chen, Hong Liang, Ming-Xiong Tan, 2011, Bioinorganic chemistry and applications.

Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin.

Hong Liang, Feng Yang, Y. Gou, 2015, Journal of inorganic biochemistry.

Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2016, European journal of medicinal chemistry.

Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2015, European journal of medicinal chemistry.

Synthesis, Cytotoxic Activity, and DNA Binding Properties of Copper (II) Complexes with Hesperetin, Naringenin, and Apigenin

Zhenfeng Chen, Hong Liang, Ming-Xiong Tan, 2009, Bioinorganic chemistry and applications.

Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents

Hong Liang, Feng Yang, Guojin Huang, 2021 .

Novel Pt(ii) complexes with modified aroyl-hydrazone Schiff-base ligands: synthesis, cytotoxicity and action mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2019, Metallomics : integrated biometal science.

Antioxidant activities and transition metal ion chelating studies of some hydroxyl Schiff base derivatives

Hong Liang, Hong Liang, Yingming Pan, 2012, Medicinal Chemistry Research.

Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer

Hong Liang, Feng Yang, Xiaoyang Wu, 2016, Oncotarget.

Developing Anticancer Copper(II) Pro-drugs Based on the Nature of Cancer Cells and the Human Serum Albumin Carrier IIA Subdomain.

Hong Liang, Feng Yang, Xiaoyang Wu, 2015, Molecular pharmaceutics.

Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2018, European journal of medicinal chemistry.

Binding and Anticancer Properties of Plumbagin with Human Serum Albumin

Hong Liang, Feng Yang, Y. Gou, 2015, Chemical biology & drug design.

Mechanism of the cytotoxicity of the diazoparaquinone antitumor antibiotic kinamycin F.

Hong Liang, O. Adedayo, B. Hasinoff, 2007, Free radical biology & medicine.

High in vitro and in vivo antitumor activities of luminecent platinum(II) complexes with jatrorrhizine derivatives.

Qi-Pin Qin, Hong Liang, Ming-Xiong Tan, 2019, European journal of medicinal chemistry.

DNA binding, cytotoxicity and apoptosis induction activity of a mixed-ligand copper(II) complex with taurine Schiff base and imidazole.

Hong Liang, Feng Yang, Mei Li, 2014, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

Two telomerase-targeting Pt(ii) complexes of jatrorrhizine and berberine derivatives induce apoptosis in human bladder tumor cells.

Qi-Pin Qin, Hong Liang, Ming-Xiong Tan, 2019, Dalton transactions.

Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and Immunotherapy.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2021, Journal of medicinal chemistry.

Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.

Qi-Pin Qin, Hong Liang, Ming-Xiong Tan, 2020, Dalton transactions.

Structure and biological properties of five Pt(II) complexes as potential anticancer agents.

Hong Liang, Feng Yang, Jungang Deng, 2018, Journal of inorganic biochemistry.

Anticancer Function and ROS-Mediated Multi-Targeting Anticancer Mechanisms of Copper (II) 2-hydroxy-1-naphthaldehyde Complexes

Hong Liang, Feng Yang, Jungang Deng, 2019, Molecules.

Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex.

Zhenlei Zhang, Hong Liang, Feng Yang, 2019, Metallomics : integrated biometal science.

Synthesis, structure, protein binding, and cytotoxicity of zinc(II) complexes with tridentate NNO Schiff-base ligands

Hong Liang, Feng Yang, Mei Li, 2014 .

A novel brain-tumor-inhibiting copper(II) compound based on a human serum albumin (HSA)-cell penetrating peptide conjugate.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2019, Journal of medicinal chemistry.

Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.

Zhenlei Zhang, Hong Liang, Feng Yang, 2017, Molecular pharmaceutics.

Progallin A isolated from the acetic ether part of the leaves of Phyllanthus emblica L. induces apoptosis of human hepatocellular carcinoma BEL-7404 cells by up-regulation of Bax expression and down-regulation of Bcl-2 expression.

Hong Lu, Hong Liang, Jin-Lan Huang, 2011, Journal of ethnopharmacology.

Synthesis of a series of novel In(III) 2,6-diacetylpyridine bis(thiosemicarbazide) complexes: structure, anticancer function and mechanism.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2020, Dalton transactions.

Development of a multi-target anticancer Sn(II) pyridine-2-carboxaldehyde thiosemicarbazone complex.

Tongfu Yang, Wenjuan Li, Hongbin Sun, 2021, Dalton transactions.

Interactive Association of Drugs Binding to Human Serum Albumin

Hong Liang, Feng Yang, Yao Zhang, 2014, International journal of molecular sciences.

Designing biotin-human serum albumin nanoparticles to enhance the targeting ability of binuclear ruthenium(III) compound.

Ming Jiang, Wenjuan Li, Hong Liang, 2020, Journal of inorganic biochemistry.

A Structure-Based 3D-QSAR Study of Anthrapyrazole Analogues of the Anticancer Agents Losoxantrone and Piroxantrone

Frank S. Guziec, Hong Liang, Jennifer Lang, 2006, J. Chem. Inf. Model..

Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2017, Journal of inorganic biochemistry.

HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2018, Drug delivery.

In vivo epidermal migration requires focal adhesion targeting of ACF7

Han Liu, Wei-Jen Tang, Hong Liang, 2016, Nature Communications.

The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds.

Frank S. Guziec, Hong Liang, B. Hasinoff, 2008, Bioorganic & medicinal chemistry.

Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells.

Zhenfeng Chen, Hong Liang, Wen-ying Shen, 2021, European journal of medicinal chemistry.

A Three-Dimensional Quantitative Structure-Activity Analysis of a New Class of Bisphenol Topoisomerase IIα Inhibitors

Hong Liang, B. Hasinoff, J. Yalowich, 2008, Molecular Pharmacology.

A Three-Dimensional Quantitative Structure-Activity Relationship Study of the Inhibition of the ATPase Activity and the Strand Passing Catalytic Activity of Topoisomerase IIα by Substituted Purine Analogs

R. Shoemaker, M. Sehested, L. Jensen, 2006, Molecular Pharmacology.

ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics

Yanlei Ma, Wei-Jen Tang, J. Turner, 2017, Nature Communications.

Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer.

Ming Jiang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Multidrug Delivery Systems Based on Human Serum Albumin for Combination Therapy with Three Anticancer Agents.

Hong Liang, Feng Yang, Philbert Lee, 2016, Molecular pharmaceutics.

Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin.

Hong Liang, Feng Yang, J. Yue, 2014, European journal of medicinal chemistry.

Apoptosis of human hepatocellular carcinoma cells SMMC-7721 induced by C-3 methylidene thiazolidinedione acetic acid

Bin Liu, Hong Liang, Yi Yu, 2019 .

Discovery of an Anti-TNF-α 9-mer Peptide from a T7 Phage Display Library for the Treatment of Inflammatory Bowel Disease.

Sheng Wang, Hong Liang, Jiaojiao Wang, 2023, Journal of medicinal chemistry.

Designing Prodrugs Based on Special Residues of Human Serum Albumin.

Hong Liang, Feng Yang, Y. Gou, 2015, Current topics in medicinal chemistry.

Structural Basis of Non‐Steroidal Anti‐Inflammatory Drug Diclofenac Binding to Human Serum Albumin

Hong Liang, Feng Yang, Philbert Lee, 2015, Chemical biology & drug design.

Comparison of Binding Characterization of Two Antiviral Drugs to Human Serum Albumin

Hong Liang, Feng Yang, Xiaoyang Wu, 2014, Chemical biology & drug design.

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin.

Tongfu Yang, Zhenlei Zhang, Hong Liang, 2023, Journal of medicinal chemistry.

Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin.

Wenjuan Li, Zhenlei Zhang, Hong Liang, 2023, Journal of medicinal chemistry.

X‐ray Crystallographic and Fluorometric Analysis of the Interactions of Rhein to Human Serum Albumin

Hong Liang, Feng Yang, Philbert Lee, 2014, Chemical biology & drug design.

HSA-based anti-inflammatory therapy: a new and improved approach.

Hong Liang, Xiaoyang Wu, Nicole Lee, 2014, Future medicinal chemistry.

Human serum albumin-based design of a diflunisal prodrug.

O. Lockridge, Hong Liang, Feng Yang, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Interactive associations of drug-drug and drug-drug-drug with IIA subdomain of human serum albumin.

Hong Liang, Feng Yang, J. Yue, 2012, Molecular pharmaceutics.

Regulation of amantadine hydrochloride binding with IIA subdomain of human serum albumin by fatty acid chains.

Hong Liang, Feng Yang, Philbert Lee, 2013, Journal of pharmaceutical sciences.

Benzaldehyde levofloxacin schiff baseinduced apoptosis of human hepatocarcinoma cells

Ying Zhang, Hong Liang, B. Liu, 2016 .

Developing Anticancer Copper(II) Pro-drugs Based on the Nature of Cancer Cells and the Human Serum Albumin Carrier IIA Subdomain.

Hong Liang, Feng Yang, Xiaoyang Wu, 2015, Molecular pharmaceutics.

A full-spectrum responsive B-TiO2@SiO2-HA nanotheranostic system for NIR-II photoacoustic imaging-guided cancer phototherapy.

Changping Ruan, Xingcan Shen, Hong Liang, 2021, Journal of materials chemistry. B.

Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Editorial: The developments of metal-based agents against lung cancer

Li Liu, Hong Liang, Y. Gou, 2022, Frontiers in Pharmacology.

Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2017, Journal of inorganic biochemistry.

Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.

Zhenlei Zhang, Hong Liang, Feng Yang, 2017, Molecular pharmaceutics.

[The effect of gallic acid extracted from leaves of Phyllanthus emblica on apoptosis of human hepatocellular carcinoma BEL-7404 cells].

Hong Liang, Chunyuan Zeng, Jin-Lan Huang, 2009, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

Developing a Hetero-Trinuclear Erbium(III)-Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Human Serum Albumin-Platinum(II) Agent Nanoparticles Inhibit Tumor Growth Through Multimodal Action Against the Tumor Microenvironment.

Zhenlei Zhang, Hong Liang, Minghui Zhu, 2023, Molecular pharmaceutics.